|
Office fédéral de la santé publique, & Bundesamt für Gesundheit. (1998). Interprétation de l'évaluation sommaire de la campagne de l'OFSP “Drogue : rester lucide”. Berne; Bern: Office fédéral de la santé publique (OFSP); Bundesamt für Gesundheit (BAG).
Keywords: government and politics; Switzerland
|
|
|
Bundesamt für Gesundheit. (1995). Statusbericht über das Projekt “Ärztliche Verschreibung von Betäubungsmitteln in der Schweiz”. Berne: Bundesamt für Gesundheit (BAG).
Keywords: government and politics; Switzerland
|
|
|
Observatoire européen des drogues et des toxicomanies. (2004). Rapport annuel 2004 : état du phénomène de la drogue dans l'Union Européenne et en Norvège. Luxembourg: Office des publications officielles des Communautés européennes.
Keywords: government and politics; international area; AOD public policy strategy; public policy on illicit drugs; other drug laws; target group; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; treatment and maintenance; prison; AODR crime; comorbidity; Europe; annual report
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2004). Annual report 2004 : the state of the drugs problem in the European Union and Norway. Luxembourg: Office for Official Publications of the European Communities.
Keywords: government and politics; international area; AOD public policy strategy; public policy on illicit drugs; other drug laws; target group; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; treatment and maintenance; prison; AODR crime; comorbidity; Europe; annual report
|
|
|
Groupement romand d'études sur l'alcoolisme et les toxicomanies, & Ateliers romands pour intervenants dans le domaine des addictions. (1997). Formation continue : perfectionnement professionnel : rapport final ARIA II. Yverdon-les-Bains: Groupement romand d'études sur l'alcoolisme et les toxicomanies (GREAT); Ateliers romands pour intervenants dans le domaine des addictions (ARIA).
|
|
|
Health Protection Agency, Scottish Centre for Infection and Environmental Health, National Public Health Service for Wales, Communicable Disease Surveillance Centre Northern Ireland, Centre for Research on Drugs and Health Behaviour, & Unlinked Anonymous Surveys Steering Group. (2003). Shooting up : infections among injecting drug users in the United Kingdom 2002. London: Health Protection Agency (HPA).
Keywords: Intravenous drug user; infection; HIV infection; viral hepatitis; hepatitis C; hepatitis B; hepatitis A; needle sharing; personal hygiene; United Kingdom
|
|
|
Unlinked Anonymous Surveys Steering Group. (2002). Prevalence of HIV and hepatitis infections in the United Kingdom 2001 : annual report of the Unlinked Anonymous Prevalence Monitoring Programme. London: Department of Health.
Abstract: The Unlinked Anonymous Prevalence Monitoring Programme began in 1988, and was aimed at measuring the distribution of infection, especially HIV, in accessible groups of the adult population. The programme provides estimates of HIV infection among groups in whom a substantial proportion of infections are undiagnosed and therefore not ascertained by other surveillance systems. Essential public health information on the prevalence of HIV infection in these groups cannot be obtained any other way. This report summarises programme data to the end of 2001.
Keywords: HIV infection; viral hepatitis; hepatitis C; infection; prevalence; public health; United Kingdom; annual report
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2002). Workgroup on costs and cost-effectiveness of interventions : executive summary. Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Keywords: AOD use, abuse, and dependence; cost (economic); cost-effectiveness; prevention; viral hepatitis; hepatitis B; hepatitis C; international area; Europe
|
|
|
European Monitoring Centre for Drugs and Drug Addiction. (2002). Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs. Luxembourg: Office for Official Publications of the European Communities.
Abstract: Since the mid-1990s, ketamine – widely used in human and veterinary medicine for 30 years – has been surfacing as a recreational drug. Concern over ketamine centres on its unpredictability in producing ‘near-death’ experiences. The risk-assessment exercise was carried out in 2000 in the framework of the Joint action on new synthetic drugs. In March 2001, the EU Justice and Home Affairs Council adopted formal conclusions that Member States should monitor this drug closely. This publication records the findings and conclusions of the exercise. Among others, it draws together the various elements used to assess the substance including: the final risk-assessment report; contributions from Europol and the European Agency for the Evaluation of Medicinal Products; a review of pharmacotoxicological data; epidemiological evidence on the associated public-health risks and sociological and criminological evidence.
Keywords: ketamine; monitoring; risk assessment; designer drug; research chemical; report; Europe
|
|
|
Health Protection Agency, Scottish Centre for Infection and Environmental Health, National Public Health Service for Wales, Communicable Disease Surveillance Centre Northern Ireland, Centre for Research on Drugs and Health Behaviour, & Unlinked Anonymous Surveys Steering Group. (2004). Shooting up : infections among injecting drug users in the United Kingdom 2003. London: Health Protection Agency (HPA).
Keywords: Intravenous drug user; infection; HIV infection; viral hepatitis; hepatitis C; hepatitis B; hepatitis A; needle sharing; personal hygiene; United Kingdom
|
|